Quantcast

Posts related to ‘POZN’

Top 10 Analyst Upgrades and Downgrades (APC, CRUS, LULU, MPEL, NFLX, NTAP, ODP, POZN, VRTX, WX)

Posted: May 14, 2010 at 8:16 am

These are ten of the top analyst upgrades, downgrades, and initiations seen in Wall Street research calls this Friday: Anadarko Petroleum Corporation (NYSE: APC) Raised to Overweight at JPMorgan. Cirrus ...
Read Full Story »

The Twitter-24/7 Wall St. Stock Market Report 5.4 The Wisdom Of Crowds?

Posted: May 4, 2010 at 8:49 am

Twitter has, by most estimates, 100 million members, which makes it one of the largest social networks in the world. All major media companies are on Twitter and some have ...
Read Full Story »

Top Day Trader Alerts (BPAX, BP, FTBK, GS, POZN, SIRI)

Posted: May 3, 2010 at 8:58 am

These are this morning's top day trader and active trader alerts.  We have a link to more detail and analysis on each where applicable at VSInvestor.com: Biosante Pharmaceuticals, Inc. (NASDAQ: ...
Read Full Story »

The Twitter-24/7 Wall St. Stock Market Report 5.3 The Wisdom Of Crowds?

Posted: May 3, 2010 at 8:46 am

Twitter has, by most estimates, 100 million members, which makes it one of the largest social networks in the world. All major media companies are on Twitter and some ...
Read Full Story »

The Unusual Suspects (BP, DNDN, ETFC, GE, JNJ, NFG, PALM, BPOP, POZN, SIRI)

Posted: May 1, 2010 at 9:44 am

Next week is still a deep earnings week, but we tried and tried to keep this weekend's edition of The Unusual Suspects as free and clear from earnings as we ...
Read Full Story »

Top Pre-Market Analyst Downgrades (CENT, HELE, INTC, LBY, MET, MNST, POZN, PRU)

Posted: October 20, 2008 at 6:48 am

These are some of the top analyst downgrades we are seeing early this Monday morning:Central Garden & Pet (CENT) Cut to Underperform at Jefferies.Helen of Troy (HELE) Cut to Hold ...
Read Full Story »

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

Posted: April 16, 2008 at 11:18 am

If you thought biotech news was getting quiet going into earnings season, think again.Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on pimavanserin, a treatment  for Parkinson’s disease psychosis (PDP) ...
Read Full Story »

Pozen (POZN): Another Microcap Biotech Falls Apart

Posted: August 2, 2007 at 8:42 am

Pozen (POZN) got the bad news that the FDA has "delayed approval of an experimental two-in-one migraine drug from GlaxoSmithKline (GSK)", according to Reuters.  The drug, Trexima combines Glaxo's popular ...
Read Full Story »